Brainsway (BWAY) Depreciation & Amortization (CF) (2018 - 2026)
Brainsway (BWAY) posted quarterly Depreciation & Amortization (CF) of $167000.0 for Q1 2026, down 12.57% year-on-year from $191000.0 in Q1 2025, and up 45.22% on a QoQ basis from $115000.0 in Q4 2025.
Brainsway (BWAY) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
Brainsway (BWAY) has reported Depreciation & Amortization (CF) for 9 consecutive years, with $167000.0 the latest figure, recorded in Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 12.57% year-over-year to $167000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $641000.0 (down 18.76% YoY) and the FY2025 annual result came in at $665000.0, up 0.76% from the prior year.
- Depreciation & Amortization (CF) advanced to $167000.0 in Q1 2026 per BWAY's latest filing, from $115000.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for BWAY reached as high as $352000.0 in Q4 2024 and fell as low as $58000.0 in Q2 2024.
- A 5-year average of $141823.5 and a median of $142000.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2024 — Depreciation & Amortization (CF) jumped 324.1% — and 2025, when it slumped 67.33%.
- Year by year, Depreciation & Amortization (CF) stood at $101000.0 in 2022, then slipped by 17.82% to $83000.0 in 2023, then jumped by 324.1% to $352000.0 in 2024, then sank by 67.33% to $115000.0 in 2025, then jumped by 45.22% to $167000.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $167000.0, $115000.0, and $179000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn | 167,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 167,000.00 |
| Mar 31, 2026 | 167,000.00 |
| Dec 31, 2025 | 115,000.00 |
| Dec 31, 2025 | 115,000.00 |
| Sep 30, 2025 | 179,000.00 |
| Sep 30, 2025 | 179,000.00 |
| Jun 30, 2025 | 180,000.00 |
| Jun 30, 2025 | 180,000.00 |
| Mar 31, 2025 | 191,000.00 |
| Mar 31, 2025 | 191,000.00 |
| Dec 31, 2024 | 352,000.00 |
| Dec 31, 2024 | 352,000.00 |
| Sep 30, 2024 | 188,000.00 |
| Sep 30, 2024 | 188,000.00 |
| Jun 30, 2024 | 58,000.00 |
| Jun 30, 2024 | 58,000.00 |
| Mar 31, 2024 | 62,000.00 |
| Mar 31, 2024 | 62,000.00 |
| Dec 31, 2023 | 83,000.00 |
| Dec 31, 2023 | 83,000.00 |